Our data clearly demonstrate that IL-10-treated adipose stromal vascular cells could be used as a novel cell therapy strategy to alleviate liver glucose gluconeogenesis and insulin resistance in T2DM. The gene discussed is IL10; the disease is type 2 diabetes mellitus.